⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CMPX News
Compass Therapeutics, Inc. Common Stock
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
globenewswire.com
CMPX
Compass Therapeutics to Participate in Upcoming November Investor Events
globenewswire.com
CMPX